AtlantiCann Medical

What AtlantiCann Medical does

AtlantiCann Medical Inc. is a privately held Canadian licensed cannabis producer headquartered in Lower Sackville, Nova Scotia, operating a purpose-built indoor cultivation and production facility in Dartmouth. The company runs an end-to-end vertical operation spanning four integrated functions: indoor cultivation using Rockwool substrate and single-cultivar rooms with pesticide-free biological control; a Genetics House and Tissue Culture Lab for boutique strain development and breeding; post-production processing including hang-drying, hand-trimming, slow curing, and irradiation-free microbial control; and a hydrocarbon extraction lab producing live resin and cured resin from fresh-frozen flower without distillates or additives.

The company generates revenue primarily through wholesale cannabis product sales to provincial distribution boards and licensed retailers across 10 Canadian provinces (Nova Scotia, Ontario, Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Prince Edward Island, Quebec, and Saskatchewan), supplemented by direct medical cannabis sales to patients through the Optimus Cannabis program. Its brand portfolio includes EastCann as the core consumer brand (dried flower, pre-rolls, vapes, edibles, soft gels), alongside partner brands IRIS Labs and FOUR54. AtlantiCann holds three quality certifications: EU-GMP (2022), ICANN G.A.P. (2023), and GACP (2023), positioning it for both domestic distribution and potential international pharmaceutical-grade export.

AtlantiCann targets two primary customer segments: medical cannabis patients seeking pharmaceutical-grade products and recreational adult-use consumers seeking premium quality flower and concentrates, with provincial distribution boards serving as the B2B channel layer. The company maintains a headcount of 51-100 employees and is led by founder Christine Halef, with ownership structure not publicly disclosed. Founder Christine Halef and a team of legacy growers with 20+ years of cultivation experience form the production backbone, distinguishing AtlantiCann from purely capital-built entrants in the Canadian LP market.

Name

AtlantiCann Medical

Legal name

AtlantiCann Medical Inc.

Website

https://atlanticann.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

AtlantiCann Medical is a privately held, purpose-built Canadian licensed cannabis producer in Nova Scotia that cultivates, processes, and distributes premium indoor-grown flower, concentrates, and branded products (EastCann, IRIS Labs, FOUR54) through 10 Canadian provincial boards and direct medical sales.

Ownership category

akta.pro rank

Headquarters

HQ city

Lower Sackville

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Cannabis Product Sales: Revenue generated from sale of cultivated cannabis products including dried flower, pre-rolls, extracts, and branded consumer products through wholesale distribution to provincial retailers.
2. EastCann Branded Products: Sale of branded cannabis products including dried flower, pre-rolls, vapes, edibles, and soft gels through retail channels across Canadian provinces.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

AtlantiCann Medical is a Canadian licensed cannabis producer that cultivates and manufactures cannabis products — including dried flower, pre-rolls, vapes, edibles, soft gels, and extracts such as live resin and cured resin — at a purpose-built facility located in Lower Sackville/Dartmouth, Nova Scotia. The company markets its products under multiple owned brands (EastCann, IRIS Labs, and FOUR54) and supplies them to provincial cannabis retailers across Canada, while also engaging in direct-to-consumer sales.

Product overview

AtlantiCann Medical is a purpose-built cannabis production facility in Nova Scotia, Canada operating as a single unified platform with end-to-end capabilities. The company integrates four core production functions: Cultivation Services (indoor growing with pesticide-free methods), Genetics House & Tissue Culture Lab (proprietary genetics development), Post Production (hang-drying, hand-trimming, slow curing), and Extraction Lab (hydrocarbon-based live resin and cured resin). The company also distributes branded products through its portfolio brands including EastCann (dried flower, pre-rolls, vapes, edibles, soft gels), IRIS Labs, and FOUR54.

Differentiator

Problem solved

Functional benefit

Brands

• EastCann: Legacy growers cultivating quality cannabis products; partner brand of AtlantiCann located in Dartmouth, Nova Scotia
• IRIS Labs
• FOUR54

Products and services

• Dried Flower
• Pre-rolls
• Cannabis Vapes
• Cannabis Edibles
• Cannabis Soft Gels
• Live Resin
• Cured Resin

Quantifiable outcome

• Exceptional potency and large buds through controlled indoor cultivation
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature11 records

Partnerships

Three partnerships are on record, tiered core and minor.

• EastCanncoreChannel Partner/ Reseller/ DistributorEastCann is a brand partner of AtlantiCann Medical, producing legacy grower quality cannabis products including dried flower, pre-rolls, vapes, edibles, and soft gels. Located in Dartmouth, Nova Scotia with operations spanning multiple Canadian provinces.
• IRIS LabsminorStrategic or Co-development PartnerIRIS Labs is listed as a brand partner of AtlantiCann Medical, representing a strategic partnership in the cannabis industry ecosystem.
• FOUR54minorStrategic or Co-development PartnerFOUR54 is listed as a brand partner of AtlantiCann Medical, representing a strategic partnership in the cannabis industry ecosystem.

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Emerging players

• Village Farms International: Canadian cannabis producer operating greenhouse and indoor cultivation with EU-GMP capability and a focus on premium dried flower. Comparable in regulatory positioning and pursuit of international medical markets.

Direct peers

• OrganiGram Holdings: Canadian licensed producer headquartered in Atlantic Canada (Moncton, New Brunswick) operating indoor cultivation, a multi-brand portfolio, and serving provincial wholesalers across Canada — directly comparable scale, geography, and go-to-market model to AtlantiCann Medical.
• High Tide Inc. Vertically integrated Canadian cannabis company combining licensed production with a large retail footprint (Canna Cabana). Comparable in multi-brand, wholesale-plus-retail strategy and Atlantic Canada operating presence.
• Decibel Cannabis: Canadian licensed producer operating indoor cultivation and a wholesale-driven multi-brand portfolio (Qwest, General Admission, Vox). Comparable mid-tier LP profile focused on craft flower and provincial wholesale distribution.
• Aurora Cannabis: Major Canadian licensed producer with EU-GMP certified facilities, multi-brand strategy (including craft brands), and a vertically integrated cultivation-to-extraction model. Comparable in regulatory positioning and product breadth, though substantially larger in scale.
• SNDL Inc. Canadian cannabis operator combining licensed production with retail banners (Value Buds, Spiritleaf). Comparable in operating LP functions and provincial distribution, with added downstream retail exposure AMI does not have.
• Auxly Cannabis Group: Canadian licensed producer with a portfolio of branded products (Kolab, Foray, Back Forty) distributed through provincial wholesalers. Comparable mid-cap LP running a multi-brand, wholesale-first model similar to AMI's EastCann-led strategy.

Broad incumbents

• Canopy Growth: Largest Canadian licensed producer with EU-GMP certified facilities, an extensive brand portfolio, and significant wholesale and medical channel presence. Sets the competitive benchmark for premium Canadian flower and extracts that AMI competes against on provincial shelves.
• Cronos Group: Canadian licensed producer with EU-GMP-certified facilities, established provincial distribution, and a brand portfolio spanning premium and value tiers. Larger scale than AMI but directly comparable in product mix and channel strategy.
• Tilray Brands: One of Canada's largest licensed producers with EU-GMP certification, significant European medical distribution infrastructure, and a diversified brand portfolio spanning flower, vapes, edibles, and extracts — a broader incumbent operating across multiple geographies that AMI's export thesis would target.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/msikuofficial
• Facebookfacebook.com/msikuofficial

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AtlantiCann Medical